LOS ANGELES (Reuters) - Billionaire Patrick Soon-Shiong plans to take an experimental cancer treatment company public this year and has begun hiring bankers, the biotechnology entrepreneur told ...

Dr. Sam S. Chang, Professor of Urology at Vanderbilt Cancer Program, to host the program “A Deep Dive with Patrick Soon-Shiong: Next-Generation Immunotherapy for NMBIC” Discussion about the basis for ...

Dr. Soon-Shiong’s priority will be to continue to align scientific and medical goals that are focused on the delivery of cutting-edge therapeutics for patients. The role connects Dr. Soon-Shiong’s ...

WASHINGTON — Federal health officials posted a warning Tuesday about misleading statements made by biotech billionaire Dr. Patrick Soon-Shiong, who recently told podcast listeners that his company's ...

Los Angeles Times owner Patrick Soon-Shiong announced plans to take the 143-year-old newspaper public within the next year, What Happened: On a Monday television interview on “The Daily Show,” ...

Add Yahoo as a preferred source to see more of our stories on Google. It wasn’t a coincidence that Kevin Merida did not call his boss, Los Angeles Times owner Patrick Soon-Shiong, to warn him that a ...

Culver City-based immunotherapy developer ImmunityBio has received $470M in equity and debit financing from its founder, Dr. Patrick Soon-Shiong, the company said this morning. According to ...

(MENAFN- GlobeNewsWire - Nasdaq) Executive Accountability: Patrick Soon-Shiong Named in Securities Action NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors that Dr.

ImmunityBio, Inc. ( NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that OncoDaily has recognized Dr. Patrick Soon-Shiong as being one of “The 100 Most Influential People in ...